Bayer Acquires Monsanto

On September 14, Bayer and Monsanto announced that they signed a definitive agreement under which Bayer will acquire Monsanto in an all-cash transaction.

“We are pleased to announce the combination of our two great organizations. This represents a major step forward for our Crop Science business and reinforces Bayer’s leadership position as a global innovation driven Life Science company with leadership positions in its core segments, delivering substantial value to shareholders, our customers, employees and society at large,” said Werner Baumann, CEO of Bayer AG.

This realizes the companies’ shared vision of integrated offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of growers. The combination brings together two different, but highly complementary businesses. The combined business will benefit from Monsanto’s leadership in Seeds & Traits and Climate Corporation platform along with Bayer’s broad Crop Protection product line across a comprehensive range of indications and crops in all key geographies.

The combination also brings together both companies’ leading innovation capabilities and R&D technology platforms. Over the mid to long-term, the combined business will be able to accelerate innovation and provide customers with enhanced solutions and an optimized product suite. These are expected to result in significant and lasting benefits from improved sourcing and increased convenience to higher yield, better environmental protection and sustainability.

The combined agriculture business will have its global Seeds & Traits and North American commercial headquarters in St. Louis, Missouri, its global Crop Protection and overall Crop Science headquarters in Monheim, Germany, and a presence in Durham, North Carolina, as well as many other locations throughout the U.S. and around the world.